RNA-based adjuvant to enhance the immune response to vaccines and therapeutics
Grant
US12582711B2
Kind: B2
Mar 24, 2026
Assignee
IMMUNESURE LLC
Inventors
Patrick Iversen, Nickolas Kipshidze, Nodar Kipshidze
Abstract
Described herein are antisense inhibitor adjuvant compositions comprising modified nucleotide sequences complementary to a Homo sapiens interleukin 10 (IL-10) or interleukin 10 receptor alpha (IL-10RA) genes and methods for use thereof.
CPC Classifications
A61K 39/39
A61K 2039/55561
A61K 2039/55527
A61K 39/04
A61K 2039/53
A61K 39/0208
A61P 37/04
A61P 31/06
C12N 15/1136
C12N 2310/11
C12N 2310/3125
C12N 2310/321
C12N 2310/3233
C12N 15/1138
C12N 2310/3513
C12N 2320/31
Y02A 50/30
Filing Date
2022-08-18
Application No.
17820623
Claims
22